Update on advances in molecular PET in urological oncology |
| |
| Authors: | Kazuhiro Kitajima Shingo Yamamoto Kazuhito Fukushima Ryogo Minamimoto Takao Kamai Hossein Jadvar |
| |
| Institution: | 1.Department of Radiology, Division of Nuclear Medicine and PET Center,Hyogo College of Medical Center,Nishinomiya,Japan;2.Department of Urology,Hyogo College of Medicine,Nishinomiya,Japan;3.Department of Radiology, Division of Nuclear Medicine,National Center for Global Health and Medicine,Tokyo,Japan;4.Department of Urology,Dokkyo Medical University School of Medicine,Tochigi,Japan;5.Department of Radiology, Division of Nuclear Medicine, Keck School of Medicine,University of Southern California,Los Angeles,USA |
| |
| Abstract: | Integrated positron emission tomography/computed tomography (PET/CT) with 2-18F]fluoro-2-deoxy-d-glucose (18F-FDG) has emerged as a powerful tool for the combined metabolic and anatomic evaluation of many cancers. In urological oncology, however, the use of 18F-FDG has been limited by a generally low tumor uptake, and physiological excretion of FDG through the urinary system. 18F-FDG PET/CT is useful when applied to specific indications in selected patients with urological malignancy. New radiotracers and positron emission tomography/magnetic resonance imaging (PET/MRI) are expected to further improve the performance of PET in uro-oncology. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
